Biologics Across Immune-Mediated Inflammatory Diseases from the Rheumatology Perspective-the Year in Review

Biologics Across Immune-Mediated Inflammatory Diseases from the Rheumatology Perspective-the Year in Review is organized by Cleveland Clinic Center for Continuing Education and would be held during Jul 12, 2017 - Jul 12, 2019. This Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credit™.

Release Date: July 12, 2017
Expiration Date: July 12, 2019
Estimated Time of Completion: 45 minutes

Target Audience:
The online series is designed for rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, and associated allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in or using biologic therapeutics for autoimmune and inflammatory disorders.

Description:
Biologic Therapies VII: Precision Medicine in the Biologic Era online series brings together world leaders in immune-based therapies and addresses cutting-edge translational immunology and the latest data on biologic therapeutics.

Biologics Across Immune-Mediated Inflammatory Diseases from the Rheumatology Perspective - the Year in Review webcast will highlight the year’s review of biologics in rheumatology from preclinical use, trial results, newly developed biologics, and safety issues with biologic use.

Learning Objectives:
• Describe biologic use in preclinical and early RA.
• Explain results of head to head trials of biologics in RA.
• Describe new biologics developed for lupus and GPA.
• Discuss safety issues associated with biologic use.

Additional details will be posted as soon as they are available.